Human Serpin B3/SCCA1 PharmaGenie ELISA Kit (SBRS1076)

Quantitative measurement of human Serpin B3 (SCCA1, Squamous Cell Carcinoma Antigen 1) is supported by the Assay Genie research-grade ELISA kit, which has been applied in studies of hepatocellular carcinoma, lung squamous cell carcinoma, head and neck cancer, cervical neoplasia, and hepatic fibrosis. Serpin B3 is an ov-serine protease inhibitor that has been investigated as a circulating biomarker tracking disease activity, treatment response, and tumor burden in these settings. The microplate-based immunoassay uses an antibody-pair capture format with colorimetric readout, integrating with standard plate-reader workflows used in clinical and translational research laboratories.

Each kit provides reagents and consumables sufficient for 96 assays and is validated for analysis of conditioned cell culture media, plasma samples, and serum specimens. Researchers can use it to screen patient cohorts, profile case versus control populations, monitor antigen levels across longitudinal collections, or quantify release from cultured tumor and inflammatory cells. The protocol is designated research use only and supports downstream applications such as biomarker validation, disease association studies, and investigation of Serpin B3 expression in tumor microenvironments. Documentation and technical support are provided by Assay Genie.